Smoking, quitting, and psychiatric disease: A review
- 1 January 2012
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 36 (1) , 271-284
- https://doi.org/10.1016/j.neubiorev.2011.06.007
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 217 references indexed in Scilit:
- Smoking outcome by psychiatric history after behavioral and varenicline treatmentJournal of Substance Abuse Treatment, 2010
- Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid systemNeuroscience & Biobehavioral Reviews, 2010
- Insight in nAChR subtype selectivity from AChBP crystal structuresBiochemical Pharmacology, 2009
- β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco SmokingArchives of General Psychiatry, 2009
- Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effectEuropean Journal of Pharmacology, 2009
- Psychiatric diagnoses as contemporaneous risk factors for suicide attempts among adolescents and young adults: Developmental changes.Journal of Consulting and Clinical Psychology, 2009
- Varenicline Improves Mood and Cognition During Smoking AbstinenceBiological Psychiatry, 2008
- Smoking and suicide: A brief overviewDrug and Alcohol Dependence, 2008
- It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and moodProgress in Neurobiology, 2007
- A Dimensional Model of Psychopathology Among Homeless Adolescents: Suicidality, Internalizing, and Externalizing DisordersJournal of Abnormal Child Psychology, 2007